K. Friedrich

DARPin-targeting of measles virus: unique bispecificity, effective oncolysis, and enhanced safety.

A. Plückthun, K. Cichutek, K. Peng, 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

Enhanced lysis by bispecific oncolytic measles viruses simultaneously using HER2/neu or EpCAM as target receptors

A. Plückthun, K. Cichutek, C. Buchholz, 2016, Molecular therapy oncolytics.

A single amino acid substitution in the measles virus F₂ protein reciprocally modulates membrane fusion activity in pathogenic and oncolytic strains.

K. Cichutek, C. Buchholz, Steffen Prüfer, 2014, Virus research.